nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE7A—renal system—kidney cancer	0.016	0.125	CbGeAlD
Ketotifen—PDE7A—kidney—kidney cancer	0.0155	0.121	CbGeAlD
Ketotifen—PDE8A—nephron tubule—kidney cancer	0.011	0.0862	CbGeAlD
Ketotifen—PDE8B—gonad—kidney cancer	0.00998	0.0781	CbGeAlD
Ketotifen—PDE8A—cortex of kidney—kidney cancer	0.00943	0.0738	CbGeAlD
Ketotifen—PDE8A—cardiac atrium—kidney cancer	0.00897	0.0702	CbGeAlD
Ketotifen—PDE4D—cortex of kidney—kidney cancer	0.00855	0.0669	CbGeAlD
Ketotifen—PGD—nephron tubule—kidney cancer	0.0067	0.0524	CbGeAlD
Ketotifen—PGD—renal system—kidney cancer	0.00609	0.0476	CbGeAlD
Ketotifen—PGD—kidney—kidney cancer	0.00588	0.046	CbGeAlD
Ketotifen—PGD—cortex of kidney—kidney cancer	0.00573	0.0448	CbGeAlD
Ketotifen—PGD—gonad—kidney cancer	0.00546	0.0427	CbGeAlD
Ketotifen—PGD—cardiac atrium—kidney cancer	0.00545	0.0427	CbGeAlD
Ketotifen—PDE4B—cortex of kidney—kidney cancer	0.00451	0.0353	CbGeAlD
Ketotifen—PDE4B—gonad—kidney cancer	0.00429	0.0336	CbGeAlD
Ketotifen—PDE4B—cardiac atrium—kidney cancer	0.00429	0.0336	CbGeAlD
Ketotifen—Pain—Pazopanib—kidney cancer	0.00216	0.00374	CcSEcCtD
Ketotifen—Sleep disorder—Capecitabine—kidney cancer	0.00216	0.00374	CcSEcCtD
Ketotifen—Loss of consciousness—Everolimus—kidney cancer	0.00215	0.00372	CcSEcCtD
Ketotifen—Abdominal pain—Temsirolimus—kidney cancer	0.00212	0.00367	CcSEcCtD
Ketotifen—Body temperature increased—Temsirolimus—kidney cancer	0.00212	0.00367	CcSEcCtD
Ketotifen—Hypertension—Vinblastine—kidney cancer	0.00212	0.00367	CcSEcCtD
Ketotifen—Syncope—Erlotinib—kidney cancer	0.00212	0.00366	CcSEcCtD
Ketotifen—Hypertension—Everolimus—kidney cancer	0.00211	0.00365	CcSEcCtD
Ketotifen—Erythema multiforme—Dactinomycin—kidney cancer	0.0021	0.00364	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00208	0.0036	CcSEcCtD
Ketotifen—Loss of consciousness—Erlotinib—kidney cancer	0.00208	0.00359	CcSEcCtD
Ketotifen—Gastrointestinal pain—Pazopanib—kidney cancer	0.00207	0.00358	CcSEcCtD
Ketotifen—Stinging—Doxorubicin—kidney cancer	0.00205	0.00355	CcSEcCtD
Ketotifen—Dry mouth—Everolimus—kidney cancer	0.00204	0.00352	CcSEcCtD
Ketotifen—Abdominal pain—Pazopanib—kidney cancer	0.002	0.00346	CcSEcCtD
Ketotifen—Increased appetite—Capecitabine—kidney cancer	0.00199	0.00345	CcSEcCtD
Ketotifen—Infection—Everolimus—kidney cancer	0.00198	0.00343	CcSEcCtD
Ketotifen—Shock—Everolimus—kidney cancer	0.00196	0.0034	CcSEcCtD
Ketotifen—Thrombocytopenia—Vinblastine—kidney cancer	0.00196	0.0034	CcSEcCtD
Ketotifen—Thrombocytopenia—Everolimus—kidney cancer	0.00196	0.00338	CcSEcCtD
Ketotifen—Infection—Erlotinib—kidney cancer	0.00191	0.00331	CcSEcCtD
Ketotifen—Syncope—Sorafenib—kidney cancer	0.0019	0.0033	CcSEcCtD
Ketotifen—Pruritus—Temsirolimus—kidney cancer	0.0019	0.00329	CcSEcCtD
Ketotifen—Shock—Erlotinib—kidney cancer	0.0019	0.00328	CcSEcCtD
Ketotifen—Thrombocytopenia—Erlotinib—kidney cancer	0.00189	0.00326	CcSEcCtD
Ketotifen—Loss of consciousness—Sorafenib—kidney cancer	0.00187	0.00323	CcSEcCtD
Ketotifen—Diarrhoea—Temsirolimus—kidney cancer	0.00184	0.00318	CcSEcCtD
Ketotifen—Hypertension—Sorafenib—kidney cancer	0.00183	0.00317	CcSEcCtD
Ketotifen—Insomnia—Everolimus—kidney cancer	0.00181	0.00312	CcSEcCtD
Ketotifen—Paraesthesia—Vinblastine—kidney cancer	0.0018	0.00311	CcSEcCtD
Ketotifen—Weight increased—Paclitaxel—kidney cancer	0.00179	0.0031	CcSEcCtD
Ketotifen—Paraesthesia—Everolimus—kidney cancer	0.00179	0.0031	CcSEcCtD
Ketotifen—Pruritus—Pazopanib—kidney cancer	0.00179	0.0031	CcSEcCtD
Ketotifen—Irritability—Capecitabine—kidney cancer	0.00179	0.00309	CcSEcCtD
Ketotifen—Erythema multiforme—Gemcitabine—kidney cancer	0.00178	0.00308	CcSEcCtD
Ketotifen—Somnolence—Everolimus—kidney cancer	0.00178	0.00307	CcSEcCtD
Ketotifen—Dizziness—Temsirolimus—kidney cancer	0.00178	0.00307	CcSEcCtD
Ketotifen—Dry mouth—Sorafenib—kidney cancer	0.00177	0.00306	CcSEcCtD
Ketotifen—Hypertension—Sunitinib—kidney cancer	0.00176	0.00305	CcSEcCtD
Ketotifen—Insomnia—Erlotinib—kidney cancer	0.00174	0.00302	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00174	0.00301	CcSEcCtD
Ketotifen—Diarrhoea—Pazopanib—kidney cancer	0.00173	0.00299	CcSEcCtD
Ketotifen—Infection—Sorafenib—kidney cancer	0.00172	0.00298	CcSEcCtD
Ketotifen—Pain—Vinblastine—kidney cancer	0.00171	0.00297	CcSEcCtD
Ketotifen—Pain—Everolimus—kidney cancer	0.00171	0.00295	CcSEcCtD
Ketotifen—Vomiting—Temsirolimus—kidney cancer	0.00171	0.00295	CcSEcCtD
Ketotifen—Shock—Sorafenib—kidney cancer	0.00171	0.00295	CcSEcCtD
Ketotifen—Dry mouth—Sunitinib—kidney cancer	0.0017	0.00294	CcSEcCtD
Ketotifen—Thrombocytopenia—Sorafenib—kidney cancer	0.0017	0.00294	CcSEcCtD
Ketotifen—Rash—Temsirolimus—kidney cancer	0.00169	0.00293	CcSEcCtD
Ketotifen—Dermatitis—Temsirolimus—kidney cancer	0.00169	0.00293	CcSEcCtD
Ketotifen—Headache—Temsirolimus—kidney cancer	0.00168	0.00291	CcSEcCtD
Ketotifen—Dizziness—Pazopanib—kidney cancer	0.00167	0.00289	CcSEcCtD
Ketotifen—Epistaxis—Paclitaxel—kidney cancer	0.00166	0.00287	CcSEcCtD
Ketotifen—Infection—Sunitinib—kidney cancer	0.00166	0.00287	CcSEcCtD
Ketotifen—Pain—Erlotinib—kidney cancer	0.00165	0.00285	CcSEcCtD
Ketotifen—Shock—Sunitinib—kidney cancer	0.00164	0.00284	CcSEcCtD
Ketotifen—Gastrointestinal pain—Vinblastine—kidney cancer	0.00164	0.00284	CcSEcCtD
Ketotifen—Thrombocytopenia—Sunitinib—kidney cancer	0.00163	0.00283	CcSEcCtD
Ketotifen—Gastrointestinal pain—Everolimus—kidney cancer	0.00163	0.00283	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—kidney cancer	0.00162	0.00281	CcSEcCtD
Ketotifen—Vomiting—Pazopanib—kidney cancer	0.00161	0.00278	CcSEcCtD
Ketotifen—Cystitis—Doxorubicin—kidney cancer	0.0016	0.00278	CcSEcCtD
Ketotifen—Rash—Pazopanib—kidney cancer	0.00159	0.00276	CcSEcCtD
Ketotifen—Nausea—Temsirolimus—kidney cancer	0.00159	0.00276	CcSEcCtD
Ketotifen—Dermatitis—Pazopanib—kidney cancer	0.00159	0.00276	CcSEcCtD
Ketotifen—Abdominal pain—Vinblastine—kidney cancer	0.00158	0.00274	CcSEcCtD
Ketotifen—Headache—Pazopanib—kidney cancer	0.00158	0.00274	CcSEcCtD
Ketotifen—Abdominal pain—Everolimus—kidney cancer	0.00158	0.00273	CcSEcCtD
Ketotifen—Body temperature increased—Everolimus—kidney cancer	0.00158	0.00273	CcSEcCtD
Ketotifen—Gastrointestinal pain—Erlotinib—kidney cancer	0.00158	0.00273	CcSEcCtD
Ketotifen—Infection—Dactinomycin—kidney cancer	0.00157	0.00271	CcSEcCtD
Ketotifen—Thrombocytopenia—Dactinomycin—kidney cancer	0.00155	0.00267	CcSEcCtD
Ketotifen—Dry eye—Doxorubicin—kidney cancer	0.00153	0.00265	CcSEcCtD
Ketotifen—Body temperature increased—Erlotinib—kidney cancer	0.00152	0.00264	CcSEcCtD
Ketotifen—Abdominal pain—Erlotinib—kidney cancer	0.00152	0.00264	CcSEcCtD
Ketotifen—Insomnia—Sunitinib—kidney cancer	0.00151	0.00261	CcSEcCtD
Ketotifen—Nausea—Pazopanib—kidney cancer	0.0015	0.0026	CcSEcCtD
Ketotifen—Bladder pain—Doxorubicin—kidney cancer	0.0015	0.0026	CcSEcCtD
Ketotifen—Paraesthesia—Sunitinib—kidney cancer	0.0015	0.00259	CcSEcCtD
Ketotifen—Hypertension—Vincristine—kidney cancer	0.00149	0.00258	CcSEcCtD
Ketotifen—Erythema multiforme—Paclitaxel—kidney cancer	0.00149	0.00258	CcSEcCtD
Ketotifen—Pain—Sorafenib—kidney cancer	0.00148	0.00256	CcSEcCtD
Ketotifen—Weight increased—Capecitabine—kidney cancer	0.00147	0.00255	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00143	0.00247	CcSEcCtD
Ketotifen—Pain—Sunitinib—kidney cancer	0.00143	0.00247	CcSEcCtD
Ketotifen—Gastrointestinal pain—Sorafenib—kidney cancer	0.00142	0.00245	CcSEcCtD
Ketotifen—Hypertension—Gemcitabine—kidney cancer	0.00142	0.00245	CcSEcCtD
Ketotifen—Pruritus—Everolimus—kidney cancer	0.00141	0.00244	CcSEcCtD
Ketotifen—Infection—Vincristine—kidney cancer	0.0014	0.00242	CcSEcCtD
Ketotifen—Thrombocytopenia—Vincristine—kidney cancer	0.00138	0.00239	CcSEcCtD
Ketotifen—Urticaria—Sorafenib—kidney cancer	0.00138	0.00238	CcSEcCtD
Ketotifen—Diarrhoea—Vinblastine—kidney cancer	0.00137	0.00237	CcSEcCtD
Ketotifen—Body temperature increased—Sorafenib—kidney cancer	0.00137	0.00237	CcSEcCtD
Ketotifen—Abdominal pain—Sorafenib—kidney cancer	0.00137	0.00237	CcSEcCtD
Ketotifen—Diarrhoea—Everolimus—kidney cancer	0.00137	0.00236	CcSEcCtD
Ketotifen—Gastrointestinal pain—Sunitinib—kidney cancer	0.00136	0.00236	CcSEcCtD
Ketotifen—Pruritus—Erlotinib—kidney cancer	0.00136	0.00236	CcSEcCtD
Ketotifen—Epistaxis—Capecitabine—kidney cancer	0.00136	0.00235	CcSEcCtD
Ketotifen—Pain—Dactinomycin—kidney cancer	0.00135	0.00234	CcSEcCtD
Ketotifen—Tension—Paclitaxel—kidney cancer	0.00135	0.00233	CcSEcCtD
Ketotifen—Nervousness—Paclitaxel—kidney cancer	0.00133	0.00231	CcSEcCtD
Ketotifen—Infection—Gemcitabine—kidney cancer	0.00133	0.0023	CcSEcCtD
Ketotifen—Dizziness—Vinblastine—kidney cancer	0.00133	0.00229	CcSEcCtD
Ketotifen—Dizziness—Everolimus—kidney cancer	0.00132	0.00228	CcSEcCtD
Ketotifen—Body temperature increased—Sunitinib—kidney cancer	0.00132	0.00228	CcSEcCtD
Ketotifen—Abdominal pain—Sunitinib—kidney cancer	0.00132	0.00228	CcSEcCtD
Ketotifen—Diarrhoea—Erlotinib—kidney cancer	0.00132	0.00228	CcSEcCtD
Ketotifen—Thrombocytopenia—Gemcitabine—kidney cancer	0.00131	0.00227	CcSEcCtD
Ketotifen—Hepatitis—Capecitabine—kidney cancer	0.00129	0.00224	CcSEcCtD
Ketotifen—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00129	0.00223	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—kidney cancer	0.00128	0.00222	CcSEcCtD
Ketotifen—Insomnia—Vincristine—kidney cancer	0.00128	0.00221	CcSEcCtD
Ketotifen—Vomiting—Vinblastine—kidney cancer	0.00127	0.00221	CcSEcCtD
Ketotifen—Dizziness—Erlotinib—kidney cancer	0.00127	0.0022	CcSEcCtD
Ketotifen—Vomiting—Everolimus—kidney cancer	0.00127	0.0022	CcSEcCtD
Ketotifen—Paraesthesia—Vincristine—kidney cancer	0.00127	0.00219	CcSEcCtD
Ketotifen—Rash—Everolimus—kidney cancer	0.00126	0.00218	CcSEcCtD
Ketotifen—Dermatitis—Everolimus—kidney cancer	0.00126	0.00218	CcSEcCtD
Ketotifen—Headache—Vinblastine—kidney cancer	0.00126	0.00217	CcSEcCtD
Ketotifen—Headache—Everolimus—kidney cancer	0.00125	0.00216	CcSEcCtD
Ketotifen—Abdominal pain—Dactinomycin—kidney cancer	0.00125	0.00216	CcSEcCtD
Ketotifen—Body temperature increased—Dactinomycin—kidney cancer	0.00125	0.00216	CcSEcCtD
Ketotifen—Syncope—Paclitaxel—kidney cancer	0.00123	0.00213	CcSEcCtD
Ketotifen—Pruritus—Sorafenib—kidney cancer	0.00123	0.00212	CcSEcCtD
Ketotifen—Vomiting—Erlotinib—kidney cancer	0.00123	0.00212	CcSEcCtD
Ketotifen—Erythema multiforme—Capecitabine—kidney cancer	0.00122	0.00212	CcSEcCtD
Ketotifen—Rash—Erlotinib—kidney cancer	0.00122	0.0021	CcSEcCtD
Ketotifen—Dermatitis—Erlotinib—kidney cancer	0.00121	0.0021	CcSEcCtD
Ketotifen—Insomnia—Gemcitabine—kidney cancer	0.00121	0.00209	CcSEcCtD
Ketotifen—Headache—Erlotinib—kidney cancer	0.00121	0.00209	CcSEcCtD
Ketotifen—Loss of consciousness—Paclitaxel—kidney cancer	0.00121	0.00209	CcSEcCtD
Ketotifen—Pain—Vincristine—kidney cancer	0.00121	0.00209	CcSEcCtD
Ketotifen—Paraesthesia—Gemcitabine—kidney cancer	0.0012	0.00208	CcSEcCtD
Ketotifen—Nausea—Vinblastine—kidney cancer	0.00119	0.00206	CcSEcCtD
Ketotifen—Somnolence—Gemcitabine—kidney cancer	0.00119	0.00206	CcSEcCtD
Ketotifen—Nausea—Everolimus—kidney cancer	0.00119	0.00205	CcSEcCtD
Ketotifen—Diarrhoea—Sorafenib—kidney cancer	0.00119	0.00205	CcSEcCtD
Ketotifen—Hypertension—Paclitaxel—kidney cancer	0.00119	0.00205	CcSEcCtD
Ketotifen—Pruritus—Sunitinib—kidney cancer	0.00118	0.00204	CcSEcCtD
Ketotifen—Gastrointestinal pain—Vincristine—kidney cancer	0.00115	0.002	CcSEcCtD
Ketotifen—Dizziness—Sorafenib—kidney cancer	0.00115	0.00198	CcSEcCtD
Ketotifen—Pain—Gemcitabine—kidney cancer	0.00114	0.00198	CcSEcCtD
Ketotifen—Nausea—Erlotinib—kidney cancer	0.00114	0.00198	CcSEcCtD
Ketotifen—Dry mouth—Paclitaxel—kidney cancer	0.00114	0.00198	CcSEcCtD
Ketotifen—Diarrhoea—Sunitinib—kidney cancer	0.00114	0.00197	CcSEcCtD
Ketotifen—Abdominal pain—Vincristine—kidney cancer	0.00112	0.00193	CcSEcCtD
Ketotifen—Body temperature increased—Vincristine—kidney cancer	0.00112	0.00193	CcSEcCtD
Ketotifen—Infection—Paclitaxel—kidney cancer	0.00111	0.00193	CcSEcCtD
Ketotifen—Dizziness—Sunitinib—kidney cancer	0.0011	0.00191	CcSEcCtD
Ketotifen—Shock—Paclitaxel—kidney cancer	0.0011	0.00191	CcSEcCtD
Ketotifen—Vomiting—Sorafenib—kidney cancer	0.0011	0.00191	CcSEcCtD
Ketotifen—Thrombocytopenia—Paclitaxel—kidney cancer	0.0011	0.0019	CcSEcCtD
Ketotifen—Rash—Sorafenib—kidney cancer	0.00109	0.00189	CcSEcCtD
Ketotifen—Dermatitis—Sorafenib—kidney cancer	0.00109	0.00189	CcSEcCtD
Ketotifen—Headache—Sorafenib—kidney cancer	0.00109	0.00188	CcSEcCtD
Ketotifen—Diarrhoea—Dactinomycin—kidney cancer	0.00108	0.00187	CcSEcCtD
Ketotifen—Vomiting—Sunitinib—kidney cancer	0.00106	0.00183	CcSEcCtD
Ketotifen—Body temperature increased—Gemcitabine—kidney cancer	0.00106	0.00183	CcSEcCtD
Ketotifen—Rash—Sunitinib—kidney cancer	0.00105	0.00182	CcSEcCtD
Ketotifen—Dermatitis—Sunitinib—kidney cancer	0.00105	0.00182	CcSEcCtD
Ketotifen—Headache—Sunitinib—kidney cancer	0.00105	0.00181	CcSEcCtD
Ketotifen—Nausea—Sorafenib—kidney cancer	0.00103	0.00178	CcSEcCtD
Ketotifen—Insomnia—Paclitaxel—kidney cancer	0.00101	0.00175	CcSEcCtD
Ketotifen—Syncope—Capecitabine—kidney cancer	0.00101	0.00175	CcSEcCtD
Ketotifen—Paraesthesia—Paclitaxel—kidney cancer	0.00101	0.00174	CcSEcCtD
Ketotifen—Vomiting—Dactinomycin—kidney cancer	0.001	0.00174	CcSEcCtD
Ketotifen—Somnolence—Paclitaxel—kidney cancer	0.000996	0.00172	CcSEcCtD
Ketotifen—Rash—Dactinomycin—kidney cancer	0.000996	0.00172	CcSEcCtD
Ketotifen—Nausea—Sunitinib—kidney cancer	0.000991	0.00171	CcSEcCtD
Ketotifen—Loss of consciousness—Capecitabine—kidney cancer	0.00099	0.00171	CcSEcCtD
Ketotifen—Hypertension—Capecitabine—kidney cancer	0.000973	0.00168	CcSEcCtD
Ketotifen—Diarrhoea—Vincristine—kidney cancer	0.000965	0.00167	CcSEcCtD
Ketotifen—Pain—Paclitaxel—kidney cancer	0.000958	0.00166	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—kidney cancer	0.000949	0.00164	CcSEcCtD
Ketotifen—Pruritus—Gemcitabine—kidney cancer	0.000947	0.00164	CcSEcCtD
Ketotifen—Dry mouth—Capecitabine—kidney cancer	0.000938	0.00162	CcSEcCtD
Ketotifen—Nausea—Dactinomycin—kidney cancer	0.000938	0.00162	CcSEcCtD
Ketotifen—Dizziness—Vincristine—kidney cancer	0.000933	0.00161	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—kidney cancer	0.00093	0.00161	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000922	0.00159	CcSEcCtD
Ketotifen—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000916	0.00159	CcSEcCtD
Ketotifen—Diarrhoea—Gemcitabine—kidney cancer	0.000916	0.00158	CcSEcCtD
Ketotifen—Infection—Capecitabine—kidney cancer	0.000914	0.00158	CcSEcCtD
Ketotifen—Shock—Capecitabine—kidney cancer	0.000905	0.00157	CcSEcCtD
Ketotifen—Thrombocytopenia—Capecitabine—kidney cancer	0.0009	0.00156	CcSEcCtD
Ketotifen—Vomiting—Vincristine—kidney cancer	0.000897	0.00155	CcSEcCtD
Ketotifen—Urticaria—Paclitaxel—kidney cancer	0.00089	0.00154	CcSEcCtD
Ketotifen—Rash—Vincristine—kidney cancer	0.00089	0.00154	CcSEcCtD
Ketotifen—Dermatitis—Vincristine—kidney cancer	0.000889	0.00154	CcSEcCtD
Ketotifen—Abdominal pain—Paclitaxel—kidney cancer	0.000886	0.00153	CcSEcCtD
Ketotifen—Body temperature increased—Paclitaxel—kidney cancer	0.000886	0.00153	CcSEcCtD
Ketotifen—Headache—Vincristine—kidney cancer	0.000884	0.00153	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—kidney cancer	0.000877	0.00152	CcSEcCtD
Ketotifen—Vomiting—Gemcitabine—kidney cancer	0.000851	0.00147	CcSEcCtD
Ketotifen—Rash—Gemcitabine—kidney cancer	0.000844	0.00146	CcSEcCtD
Ketotifen—Dermatitis—Gemcitabine—kidney cancer	0.000843	0.00146	CcSEcCtD
Ketotifen—Headache—Gemcitabine—kidney cancer	0.000839	0.00145	CcSEcCtD
Ketotifen—Nausea—Vincristine—kidney cancer	0.000838	0.00145	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—kidney cancer	0.000834	0.00144	CcSEcCtD
Ketotifen—Insomnia—Capecitabine—kidney cancer	0.000832	0.00144	CcSEcCtD
Ketotifen—Paraesthesia—Capecitabine—kidney cancer	0.000826	0.00143	CcSEcCtD
Ketotifen—Nausea—Gemcitabine—kidney cancer	0.000795	0.00138	CcSEcCtD
Ketotifen—Pruritus—Paclitaxel—kidney cancer	0.000793	0.00137	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—kidney cancer	0.000789	0.00136	CcSEcCtD
Ketotifen—Pain—Capecitabine—kidney cancer	0.000786	0.00136	CcSEcCtD
Ketotifen—Diarrhoea—Paclitaxel—kidney cancer	0.000767	0.00133	CcSEcCtD
Ketotifen—Gastrointestinal pain—Capecitabine—kidney cancer	0.000752	0.0013	CcSEcCtD
Ketotifen—Dizziness—Paclitaxel—kidney cancer	0.000741	0.00128	CcSEcCtD
Ketotifen—Urticaria—Capecitabine—kidney cancer	0.000731	0.00126	CcSEcCtD
Ketotifen—Body temperature increased—Capecitabine—kidney cancer	0.000727	0.00126	CcSEcCtD
Ketotifen—Abdominal pain—Capecitabine—kidney cancer	0.000727	0.00126	CcSEcCtD
Ketotifen—Tension—Doxorubicin—kidney cancer	0.000713	0.00123	CcSEcCtD
Ketotifen—Vomiting—Paclitaxel—kidney cancer	0.000713	0.00123	CcSEcCtD
Ketotifen—Rash—Paclitaxel—kidney cancer	0.000707	0.00122	CcSEcCtD
Ketotifen—Dermatitis—Paclitaxel—kidney cancer	0.000706	0.00122	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—kidney cancer	0.000705	0.00122	CcSEcCtD
Ketotifen—Headache—Paclitaxel—kidney cancer	0.000702	0.00121	CcSEcCtD
Ketotifen—Nausea—Paclitaxel—kidney cancer	0.000666	0.00115	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—kidney cancer	0.000651	0.00113	CcSEcCtD
Ketotifen—Pruritus—Capecitabine—kidney cancer	0.000651	0.00113	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—kidney cancer	0.000638	0.0011	CcSEcCtD
Ketotifen—Diarrhoea—Capecitabine—kidney cancer	0.000629	0.00109	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—kidney cancer	0.000627	0.00108	CcSEcCtD
Ketotifen—Dizziness—Capecitabine—kidney cancer	0.000608	0.00105	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—kidney cancer	0.000605	0.00105	CcSEcCtD
Ketotifen—Infection—Doxorubicin—kidney cancer	0.000589	0.00102	CcSEcCtD
Ketotifen—Vomiting—Capecitabine—kidney cancer	0.000585	0.00101	CcSEcCtD
Ketotifen—Shock—Doxorubicin—kidney cancer	0.000583	0.00101	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—kidney cancer	0.00058	0.001	CcSEcCtD
Ketotifen—Rash—Capecitabine—kidney cancer	0.00058	0.001	CcSEcCtD
Ketotifen—Dermatitis—Capecitabine—kidney cancer	0.000579	0.001	CcSEcCtD
Ketotifen—Headache—Capecitabine—kidney cancer	0.000576	0.000997	CcSEcCtD
Ketotifen—Nausea—Capecitabine—kidney cancer	0.000546	0.000945	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—kidney cancer	0.000536	0.000928	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—kidney cancer	0.000532	0.000921	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—kidney cancer	0.000527	0.000912	CcSEcCtD
Ketotifen—Pain—Doxorubicin—kidney cancer	0.000507	0.000877	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000485	0.000839	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—kidney cancer	0.000471	0.000815	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—kidney cancer	0.000469	0.000811	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—kidney cancer	0.000469	0.000811	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—kidney cancer	0.000419	0.000726	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—kidney cancer	0.000406	0.000702	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—kidney cancer	0.000392	0.000678	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—kidney cancer	0.000377	0.000652	CcSEcCtD
Ketotifen—Rash—Doxorubicin—kidney cancer	0.000374	0.000647	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—kidney cancer	0.000373	0.000646	CcSEcCtD
Ketotifen—Headache—Doxorubicin—kidney cancer	0.000371	0.000642	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—kidney cancer	0.000352	0.000609	CcSEcCtD
Ketotifen—PDE4D—Signaling Pathways—IGF2—kidney cancer	0.000108	0.000367	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN2B—kidney cancer	0.000108	0.000366	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—POMC—kidney cancer	0.000108	0.000366	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PTEN—kidney cancer	0.000107	0.000363	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PTEN—kidney cancer	0.000107	0.000363	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—PIK3CA—kidney cancer	0.000106	0.000359	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—RAF1—kidney cancer	0.000105	0.000356	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IGF1R—kidney cancer	0.000104	0.000355	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—RELA—kidney cancer	0.000104	0.000355	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PTGS2—kidney cancer	0.000104	0.000355	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—ANXA1—kidney cancer	0.000104	0.000354	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—ERBB2—kidney cancer	0.000104	0.000353	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL2—kidney cancer	0.000104	0.000353	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CDKN1B—kidney cancer	0.000103	0.000351	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IGF2—kidney cancer	0.000103	0.00035	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN2B—kidney cancer	0.000102	0.000348	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MTOR—kidney cancer	0.000102	0.000348	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL2—kidney cancer	0.000101	0.000344	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—RAF1—kidney cancer	0.000101	0.000342	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IGF1R—kidney cancer	9.95e-05	0.000338	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—IL2—kidney cancer	9.94e-05	0.000338	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HIF1A—kidney cancer	9.88e-05	0.000336	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TSC2—kidney cancer	9.86e-05	0.000335	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CCND1—kidney cancer	9.86e-05	0.000335	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—JUN—kidney cancer	9.84e-05	0.000334	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CTNNB1—kidney cancer	9.76e-05	0.000332	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SFRP2—kidney cancer	9.73e-05	0.000331	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—VEGFA—kidney cancer	9.64e-05	0.000328	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—VEGFA—kidney cancer	9.64e-05	0.000328	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CDKN1B—kidney cancer	9.6e-05	0.000327	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—RAF1—kidney cancer	9.58e-05	0.000326	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IGF2—kidney cancer	9.52e-05	0.000324	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	9.52e-05	0.000324	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PTEN—kidney cancer	9.51e-05	0.000323	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN2B—kidney cancer	9.48e-05	0.000322	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—IL2—kidney cancer	9.46e-05	0.000322	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—ANXA1—kidney cancer	9.46e-05	0.000322	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KDR—kidney cancer	9.45e-05	0.000321	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL2—kidney cancer	9.4e-05	0.00032	CbGpPWpGaD
Ketotifen—PGD—Disease—MAPK3—kidney cancer	9.28e-05	0.000315	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IGF1R—kidney cancer	9.2e-05	0.000313	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CCND1—kidney cancer	9.16e-05	0.000312	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—JUN—kidney cancer	9.14e-05	0.000311	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—MAPK3—kidney cancer	9.12e-05	0.00031	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—MAPK3—kidney cancer	9.12e-05	0.00031	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PTEN—kidney cancer	9.1e-05	0.000309	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CTNNB1—kidney cancer	9.07e-05	0.000309	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	9.06e-05	0.000308	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—POMC—kidney cancer	9.03e-05	0.000307	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL2—kidney cancer	9.03e-05	0.000307	CbGpPWpGaD
Ketotifen—PGD—Disease—MYC—kidney cancer	9.03e-05	0.000307	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—MYC—kidney cancer	8.87e-05	0.000302	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—MYC—kidney cancer	8.87e-05	0.000302	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—RAF1—kidney cancer	8.87e-05	0.000301	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PTEN—kidney cancer	8.84e-05	0.000301	CbGpPWpGaD
Ketotifen—PGD—Disease—MAPK1—kidney cancer	8.83e-05	0.0003	CbGpPWpGaD
Ketotifen—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	8.79e-05	0.000299	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—IL2—kidney cancer	8.75e-05	0.000298	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KIT—kidney cancer	8.7e-05	0.000296	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—APC—kidney cancer	8.7e-05	0.000296	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—MAPK1—kidney cancer	8.68e-05	0.000295	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—MAPK1—kidney cancer	8.68e-05	0.000295	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HIF1A—kidney cancer	8.6e-05	0.000292	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—VEGFA—kidney cancer	8.59e-05	0.000292	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL2—kidney cancer	8.59e-05	0.000292	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TSC2—kidney cancer	8.58e-05	0.000292	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	8.55e-05	0.000291	CbGpPWpGaD
Ketotifen—PGD—Disease—KRAS—kidney cancer	8.34e-05	0.000284	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—MAPK3—kidney cancer	8.34e-05	0.000283	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—POMC—kidney cancer	8.29e-05	0.000282	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KDR—kidney cancer	8.23e-05	0.00028	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—KRAS—kidney cancer	8.2e-05	0.000279	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—KRAS—kidney cancer	8.2e-05	0.000279	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HIF1A—kidney cancer	8.19e-05	0.000278	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—BRAF—kidney cancer	8.18e-05	0.000278	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TSC2—kidney cancer	8.17e-05	0.000278	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—MAPK3—kidney cancer	8.13e-05	0.000276	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—VEGFA—kidney cancer	7.99e-05	0.000272	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL2—kidney cancer	7.95e-05	0.00027	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—MAPK1—kidney cancer	7.93e-05	0.00027	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—MYC—kidney cancer	7.91e-05	0.000269	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	7.86e-05	0.000267	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKAP13—kidney cancer	7.84e-05	0.000267	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP2—kidney cancer	7.84e-05	0.000267	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KDR—kidney cancer	7.83e-05	0.000266	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—MAPK1—kidney cancer	7.73e-05	0.000263	CbGpPWpGaD
Ketotifen—PGD—Disease—PIK3CA—kidney cancer	7.66e-05	0.00026	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—PIK3CA—kidney cancer	7.58e-05	0.000258	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—APC—kidney cancer	7.58e-05	0.000258	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KIT—kidney cancer	7.58e-05	0.000258	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HIF1A—kidney cancer	7.58e-05	0.000258	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MAPK3—kidney cancer	7.56e-05	0.000257	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TSC2—kidney cancer	7.56e-05	0.000257	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PIK3CA—kidney cancer	7.53e-05	0.000256	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PIK3CA—kidney cancer	7.53e-05	0.000256	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—KRAS—kidney cancer	7.49e-05	0.000255	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MYC—kidney cancer	7.35e-05	0.00025	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—KRAS—kidney cancer	7.3e-05	0.000248	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—kidney cancer	7.28e-05	0.000248	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—kidney cancer	7.28e-05	0.000248	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—MAPK3—kidney cancer	7.26e-05	0.000247	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KDR—kidney cancer	7.24e-05	0.000246	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—POMC—kidney cancer	7.21e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KIT—kidney cancer	7.21e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—APC—kidney cancer	7.21e-05	0.000245	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MAPK1—kidney cancer	7.19e-05	0.000244	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GRB7—kidney cancer	7.17e-05	0.000244	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—BRAF—kidney cancer	7.12e-05	0.000242	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	6.91e-05	0.000235	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—MAPK1—kidney cancer	6.91e-05	0.000235	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PIK3CA—kidney cancer	6.88e-05	0.000234	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—POMC—kidney cancer	6.87e-05	0.000233	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—RAF1—kidney cancer	6.83e-05	0.000232	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—RELA—kidney cancer	6.8e-05	0.000231	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—KRAS—kidney cancer	6.79e-05	0.000231	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—BRAF—kidney cancer	6.78e-05	0.000231	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—ERBB2—kidney cancer	6.76e-05	0.00023	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PIK3CA—kidney cancer	6.71e-05	0.000228	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—APC—kidney cancer	6.67e-05	0.000227	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KIT—kidney cancer	6.67e-05	0.000227	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MTOR—kidney cancer	6.67e-05	0.000227	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ITPR2—kidney cancer	6.67e-05	0.000227	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PIK3CA—kidney cancer	6.6e-05	0.000224	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	6.57e-05	0.000223	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—kidney cancer	6.52e-05	0.000222	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—kidney cancer	6.49e-05	0.000221	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PIK3CA—kidney cancer	6.42e-05	0.000218	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—MAPK3—kidney cancer	6.39e-05	0.000217	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—POMC—kidney cancer	6.35e-05	0.000216	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	6.28e-05	0.000214	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—BRAF—kidney cancer	6.27e-05	0.000213	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1B—kidney cancer	6.26e-05	0.000213	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PIK3CA—kidney cancer	6.24e-05	0.000212	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—kidney cancer	6.21e-05	0.000211	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL2—kidney cancer	6.13e-05	0.000208	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—MAPK1—kidney cancer	6.08e-05	0.000207	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNA1—kidney cancer	6.04e-05	0.000206	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—kidney cancer	6.04e-05	0.000205	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	6.01e-05	0.000204	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HSPB1—kidney cancer	6.01e-05	0.000204	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PIK3CA—kidney cancer	5.99e-05	0.000204	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCND1—kidney cancer	5.97e-05	0.000203	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—JUN—kidney cancer	5.96e-05	0.000203	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—RAF1—kidney cancer	5.95e-05	0.000202	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—RELA—kidney cancer	5.92e-05	0.000201	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—kidney cancer	5.91e-05	0.000201	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ERBB2—kidney cancer	5.88e-05	0.0002	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—kidney cancer	5.81e-05	0.000198	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MTOR—kidney cancer	5.81e-05	0.000197	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—kidney cancer	5.76e-05	0.000196	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—kidney cancer	5.74e-05	0.000195	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	5.7e-05	0.000194	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RAF1—kidney cancer	5.66e-05	0.000192	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RELA—kidney cancer	5.64e-05	0.000192	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ERBB2—kidney cancer	5.6e-05	0.00019	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ANXA1—kidney cancer	5.59e-05	0.00019	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PSMD7—kidney cancer	5.59e-05	0.00019	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TSC1—kidney cancer	5.59e-05	0.00019	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MTOR—kidney cancer	5.53e-05	0.000188	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1B—kidney cancer	5.45e-05	0.000185	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FLT1—kidney cancer	5.41e-05	0.000184	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL2—kidney cancer	5.33e-05	0.000181	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—kidney cancer	5.28e-05	0.000179	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RAF1—kidney cancer	5.24e-05	0.000178	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RELA—kidney cancer	5.21e-05	0.000177	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—kidney cancer	5.21e-05	0.000177	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCND1—kidney cancer	5.2e-05	0.000177	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—JUN—kidney cancer	5.19e-05	0.000176	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	5.19e-05	0.000176	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ERBB2—kidney cancer	5.18e-05	0.000176	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—kidney cancer	5.15e-05	0.000175	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MTOR—kidney cancer	5.11e-05	0.000174	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—POMC—kidney cancer	5.1e-05	0.000173	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL2—kidney cancer	5.08e-05	0.000173	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—kidney cancer	5.02e-05	0.000171	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JUNB—kidney cancer	5.02e-05	0.000171	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PAK1—kidney cancer	5.02e-05	0.000171	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCND1—kidney cancer	4.95e-05	0.000168	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—JUN—kidney cancer	4.94e-05	0.000168	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK3—kidney cancer	4.92e-05	0.000167	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	4.9e-05	0.000167	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1B—kidney cancer	4.8e-05	0.000163	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MYC—kidney cancer	4.79e-05	0.000163	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—kidney cancer	4.78e-05	0.000162	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL2—kidney cancer	4.7e-05	0.00016	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK1—kidney cancer	4.69e-05	0.000159	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—POMC—kidney cancer	4.63e-05	0.000158	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCND1—kidney cancer	4.58e-05	0.000156	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—JUN—kidney cancer	4.57e-05	0.000155	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—kidney cancer	4.53e-05	0.000154	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—kidney cancer	4.53e-05	0.000154	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—kidney cancer	4.43e-05	0.00015	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—kidney cancer	4.42e-05	0.00015	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—kidney cancer	4.31e-05	0.000147	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK3—kidney cancer	4.29e-05	0.000146	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MYC—kidney cancer	4.17e-05	0.000142	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF2—kidney cancer	4.1e-05	0.000139	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN2B—kidney cancer	4.08e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK3—kidney cancer	4.08e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK1—kidney cancer	4.08e-05	0.000139	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—kidney cancer	4.07e-05	0.000138	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—kidney cancer	3.99e-05	0.000136	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MYC—kidney cancer	3.97e-05	0.000135	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1R—kidney cancer	3.96e-05	0.000135	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—kidney cancer	3.93e-05	0.000134	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK1—kidney cancer	3.88e-05	0.000132	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—kidney cancer	3.85e-05	0.000131	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—RAF1—kidney cancer	3.82e-05	0.00013	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK3—kidney cancer	3.78e-05	0.000128	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL2—kidney cancer	3.77e-05	0.000128	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MYC—kidney cancer	3.67e-05	0.000125	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—kidney cancer	3.67e-05	0.000125	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK1—kidney cancer	3.59e-05	0.000122	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—kidney cancer	3.54e-05	0.00012	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL2—kidney cancer	3.43e-05	0.000116	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—kidney cancer	3.42e-05	0.000116	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—kidney cancer	3.39e-05	0.000115	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	3.37e-05	0.000115	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HIF1A—kidney cancer	3.26e-05	0.000111	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—kidney cancer	3.26e-05	0.000111	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TSC2—kidney cancer	3.26e-05	0.000111	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KDR—kidney cancer	3.12e-05	0.000106	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—kidney cancer	3.12e-05	0.000106	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—kidney cancer	3.02e-05	0.000103	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KIT—kidney cancer	2.88e-05	9.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—APC—kidney cancer	2.88e-05	9.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAPK3—kidney cancer	2.75e-05	9.36e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—POMC—kidney cancer	2.74e-05	9.31e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BRAF—kidney cancer	2.7e-05	9.19e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAPK1—kidney cancer	2.62e-05	8.91e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	2.5e-05	8.51e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—kidney cancer	2.47e-05	8.41e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	2.27e-05	7.73e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RAF1—kidney cancer	2.26e-05	7.67e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RELA—kidney cancer	2.25e-05	7.64e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.23e-05	7.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MTOR—kidney cancer	2.2e-05	7.49e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.07e-05	7.03e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL2—kidney cancer	2.02e-05	6.88e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCND1—kidney cancer	1.97e-05	6.71e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JUN—kidney cancer	1.97e-05	6.69e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.95e-05	6.64e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—kidney cancer	1.9e-05	6.47e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.72e-05	5.85e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.63e-05	5.53e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MYC—kidney cancer	1.58e-05	5.38e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.55e-05	5.26e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—kidney cancer	1.46e-05	4.97e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.34e-05	4.57e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—kidney cancer	1.3e-05	4.42e-05	CbGpPWpGaD
